We focus our research and development practice on discovering and developing new medicines for unmet medical needs. Right now, the Genentech Research and Early Development pipeline has more than 20 new molecular entities in clinical development.
Researchers are invited to submit their concept proposal via the IIS submission portal.
Our immunology program offers the experience needed to transform knowledge into practice
This convenient resource offers scientific and clinical information for US healthcare providers.
Information reimbursement denials and appeals as well as billing and coding.
We've been named to Fast Company's list of "The World's 50 Most Innovative Companies" list for making targeted, genetics-based cancer therapies.
This video series explores ongoing research by our scientists in a variety of focus areas. Watch it on YouTube.